Sichuan KELUN PHARMACEUTICAL Co., Ltd.
Sichuan KELUN PHARMACEUTICAL Co., Ltd., commonly referred to as KELUN, is a prominent player in the biopharmaceutical industry, headquartered in Chengdu, China. Established in 2004, the company has rapidly expanded its operations across various regions, focusing on the development and manufacturing of innovative pharmaceutical products. KELUN specialises in the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms, particularly in the fields of oncology and cardiovascular treatments. Their commitment to research and development has led to significant advancements, positioning them as a leader in the market. Notably, KELUN has achieved several key milestones, including successful collaborations with international partners and a robust portfolio of patented products, underscoring their dedication to excellence in the pharmaceutical sector.
DitchCarbon Score
How does Sichuan KELUN PHARMACEUTICAL Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sichuan KELUN PHARMACEUTICAL Co., Ltd.'s score of 22 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sichuan KELUN PHARMACEUTICAL Co., Ltd.'s reported carbon emissions
In 2022, Sichuan KELUN PHARMACEUTICAL Co., Ltd. reported total carbon emissions of approximately 2,372,000,000 kg CO2e. This figure includes about 2,136,000,000 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and approximately 236,000,000 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity, steam, heating, and cooling. Currently, there are no publicly disclosed reduction targets or climate pledges from the company, indicating a potential area for future commitment to sustainability and emissions reduction. As the pharmaceutical industry increasingly focuses on climate action, Sichuan KELUN PHARMACEUTICAL may consider establishing specific targets to align with global climate goals and enhance its environmental responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | |
|---|---|
| Scope 1 | 2,136,000,000 |
| Scope 2 | 236,000,000 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sichuan KELUN PHARMACEUTICAL Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
